Weiner H L
Harvard University, Boston, USA.
Hosp Pract (1995). 1995 Sep 15;30(9):53-8. doi: 10.1080/21548331.1995.11443258.
Immunologically active lymphoid tissue in gut mucosa is preferentially programmed to inhibit autoimmune reactions, a property that can be exploited by oral administration of self-antigen. Identifying the target autoantigens to use in oral preparations may not be necessary. The trigger for oral tolerization is antigen-specific, but suppressive events in the target organ are nonspecific.